« Back
Home /
Human Tissue Factor (TF) AssayMax™ ELISA Kit

Human Tissue Factor (TF) AssayMax™ ELISA Kit

Item no.	ET1002-1
Manufacturer	Assaypro
Amount	96 Well Plate
Category	Oncology Metabolism Glucose Homeostasis Cholesterol & Lipid Metabolism ELISA ELISA & Immunoassays ELISA Kits Immunoassay By Organ Lung Cancer
Type	Elisa-Kit
Applications	ELISA
Specific against	Human (Homo sapiens)
Citations	* Siddiqui FA et al. (2002) The presence and release of tissue factor from human platelets. Platelets 13(4):247-253 * Jesmin S et al. (2004) Temporal changes in pulmonary expression of key procoagulant molecules in rabbits with endotoxin-induced acute lung injury: elevated expression levels of protease-activated receptors. Thromb Haemost. 92(5):966-979 * Henriksson CE et al. (2005) Discrepancy between tissue factor activity and tissue factor expression in endotoxin-induced monocytes is associated with apoptosis and necrosis. Thromb Haemost. 94(6):1236-44 * Roth GA et al. (2006) Infection with a periodontal pathogen induces procoagulant effects in human aortic endothelial cells. Journal of Thrombosis and Haemostasis 4(10):2256-2261 * Sawa H et al. (2006) Elevation of plasma tissue factor levels in patients with severe acute pancreatitis. J. Gastroenterol. 41(6):575-581 * Emekli-Alturfan E et al. (2007) The Relation between Plasma Tissue Factor and Oxidized LDL Levels in Acute Coronary Syndromes. Pathophysiol Haemost Thromb. 36(6):290-297 * Han J et al. (2008) An anticoagulant serine protease from the wasp venom of Vespa magnifica. Toxicon 51(5):914-922 * He WJ et al. (2008) Activated protein C ratio, plasma tissue factor activity and activated factor VII in Chinese patients with coronary heart disease. Eur J Med Res. 13:47-51 * Jiang DJ et al. (2009) Asymmetric dimethylarginine induces tissue factor expression in monocytes via NF-kappaB-dependent pathway: Role in acute coronary syndromes. Atherosclerosis 205(2):554-560 * Teng YC et al. (2009) Coagulation and fibrinolysis related cytokine imbalance in preeclampsia: the role of placental trophoblasts. J. Perinat. Med. 37:343-348 * Andersson E et al. (2010) Tissue factor in predicted severe acute pancreatitis. World J Gastroenterol 16(48): 6128-6134 * Munuswamy-Ramanujam G et al. (2010) Neuroserpin, a thrombolytic serine protease inhibitor (serpin), blocks transplant vasculopathy with associated modification of T-helper cell subsets. Thromb Haemost. 103(3):545-555 * Strijbos MH et al. (2010) Circulating endothelial cells, circulating tumour cells, tissue factor, endothelin-1 and overall survival in prostate cancer patients treated with docetaxel. European Journal of Cancer 46:2027-2035 * Teng Y et al. (2010) The relationship between plasma and placental tissue factor, and tissue factor pathway inhibitors in severe pre-eclampsia patients. Thrombosis Research 126(1):e41-e45 * Watson T et al. (2010) Relationship of Indices of Inflammation and Thrombogenesis to Arrhythmia Burden in Paroxysmal Atrial Fibrillation. Chest. 137(4):869-876 * Jiang WH et al. (2011) Regulatory role of RhoA/Rho kinase in the effect of fluvastatin on tumor necrosis factor-alpha induced expression of tissue factor. Afr. J. Pharm. Pharmacol. 5(12):1462-1466 * Priya N et al. (2011) Characterization of a unique dihydropyrimidinone, ethyl 4-(4-heptanoyloxyphenyl)-6-methyl-3,4-dihydropyrimidin-2-one-5-carboxylate, as an effective antithrombotic agent in a rat experimental model. Journal of Pharmacy and Pharmacology 63(9):1175-1185 * Wang Y et al. (2011) Prediction of response to docetaxel therapy based on the presence of tmprssg2:erg fusion in circulating tumor cells. USPTO Patent Applicaton #: #20110166030 * Xiong Y et al. (2011) Alternations of Maternal and Cord Plasma Hemostasis in Preeclampsia Before and After Delivery. Hypertens Pregnancy. 30(3):347-358 * Fernandez-Cadenas I et al. (2012) IL1B and VWF variants are associated with fibrinolytic early recanalization in patients with ischemic stroke. Stroke. 43(10):2659-2665 * Santos MJ (2012) Early Vascular Alterations in SLE and RA Patients--A Step towards Understanding the Associated Cardiovascular Risk. PLoS One. 7(9):e44668.doi: 10.1371/journal.pone.0044668 * Zhu H et al. (2012) Activation of coagulation, anti-coagulation, fibrinolysis and the complement system in patients with urticaria. Asian Pac J Allergy Immunol 31:43-50 * Kohno K et al. (2013) Therapeutic agent for inflammary diseases, containing adenosine N1-Oxide as an effective ingredient. Patent application: 20130165399 A1
ECLASS 10.1	32160605
ECLASS 11.0	32160605
UNSPSC	41116126
Available
Manufacturer - Type	AssayMax™ ELISA Kits
Manufacturer - Category	ELISA_Activity_Kits
Associated Disease	Cancer
Description	This assay employs a quantitative enzyme immunoassay technique that measures the specified antigen in samples.
Note	For Research Use Only
Omim	134390
Unigene	Hs.62192
Format	Sandwich ELISA
Samples	Serum, Plasma, Cell Culture, Tissue Extract

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

ET1002-1-safety-datasheet.pdf